Visudyne (QLT Ophthalmics, Inc.)


Welcome to the PulseAid listing for the Visudyne drug offered from QLT Ophthalmics, Inc.. This Photoabsorption [MoA],Photoenhancer [EPC],Photosensitizing Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: QLT Ophthalmics, Inc.
NON-PROPRIETARY NAME: verteporfin for injection
SUBSTANCE NAME: VERTEPORFIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Photoabsorption [MoA],Photoenhancer [EPC],Photosensitizing Activity [PE]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2000-04-12
END MARKETING DATE: 0000-00-00


Visudyne HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVisudyne from QLT Ophthalmics, Inc.
LABELER NAME: QLT Ophthalmics, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 15(mg/1)
START MARKETING DATE: 2000-04-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50236-001_41e7889e-a183-4fea-9e12-63052f878cc0
PRODUCT NDC: 50236-001
APPLICATION NUMBER: NDA021119

Other VERTEPORFIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
QLT Ophthalmics, Inc.Visudyne
Valeant Pharmaceuticals North America LLCVisudyne